Itrakris 200mg Capsule contains Itraconazole, a broad-spectrum triazole antifungal agent used for the treatment of various fungal infections. Itraconazole exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This medication is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, and onychomycosis, as well as infections caused by Candida species. Itrakris 200mg is administered orally and is well-absorbed in the gastrointestinal tract, with enhanced bioavailability when taken with food. The dosage and duration of therapy depend on the type and severity of the infection, and treatment should be guided by clinical response and microbiological data. Caution is advised in patients with hepatic impairment, and periodic liver function monitoring is recommended during prolonged therapy. Itraconazole may interact with several medications due to its effect on cytochrome P450 enzymes, necessitating careful review of concomitant drugs. Common adverse effects include gastrointestinal disturbances, headache, and rash. Itrakris 200mg Capsule should be used under medical supervision to ensure safety and efficacy in the treatment of fungal infections.